Navigation Links
Varian Medical Systems to Celebrate Tenth Anniversary and Decade of Growth
Date:4/2/2009

PALO ALTO, Calif., April 2 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) today is celebrating its tenth anniversary and a decade of growth and innovation in life-saving technology utilizing X-ray energy for cancer treatment, imaging, and security and inspection.

Varian Medical Systems emerged as a stand-alone company on April 2, 1999 following the division of Varian Associates, a 51-year-old Silicon Valley pioneer, into three separate companies focused on medical technology, semiconductor manufacturing, and scientific instruments.

"We have a lot to celebrate," said Tim Guertin, president and CEO of Varian Medical Systems. "We have built a growing business based on our mission of focusing energy on protecting and saving lives. We have revolutionized radiotherapy and radiosurgery for treating cancer, paved the way for lower-cost filmless X-ray imaging, and developed systems for fast, automatic detection of threats in cargo moving through ports and borders."

Varian Medical Systems is now bigger than its parent company was at the time of the division. The company nearly quadrupled its annual revenues, growing from $542 million in fiscal 1998 to $2.1 billion in fiscal 2008. It increased annual operating earnings from $24 million to $419 million over the same period while growing annual net earnings grew from $8 million to $295 million.

Scores of new products were introduced during the decade, in each of Varian's areas of business:

  • Radiation Oncology: Varian has revolutionized radiotherapy and radiosurgery with innovations that are making it more precise, accurate, effective, and affordable as well as more comfortable for patients. Varian has introduced technology for intensity-modulated radiation therapy (IMRT), image-guided radiothe
    '/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ovarian cancer screening not catching early disease
2. Doctors at Henry Ford Health System Treat Ovarian, Prostate, Lung, and Other Forms of Cancer Using Novalis Tx(TM) Platform for Image-Guided Radiosurgery
3. Varian Medical Systems Schedules Second Quarter FY2009 News Release and Conference Call
4. Catching Ovarian Cancer Early May Miss Aggressive Tumors
5. Ovarian cancers detected early may be less aggressive, questioning effectiveness of screening
6. Study IDs Gene Variants Tied to Sudden Cardiac Death
7. Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
8. Combo Screening Doesnt Spot Early Ovarian Cancer
9. Early Detection Remains Key in Updated NCCN Guidelines for Ovarian Cancer
10. Combo of Tests Might Spot Ovarian Cancer Early
11. Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Georgia (PRWEB) August 27, 2014 ... of PartnerTech AB, a major systems integration and ... Impact Cryotherapy offering the first U.S. designed ... Inc. offered the ideal combination of manufacturing expertise, ... cryotherapy system. Impact Cryotherapy, headquartered in Atlanta, GA, ...
(Date:8/26/2014)... Hearing aids are not always ... plan holders to determine what their hearing care benefits are. ... additional health plans and has published benefit details on their ... , The following is a list of insurances or ... , NYSHIP/ NYS Empire Plan - Hearing Aid Benefit is ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 Leelanau ... a fabulous time to visit the region’s wineries. Rolling ... backdrop to wine tasting fun in a weekend event ... Kicking off the festivities is an optional race through ... Vineyards in Suttons Bay. A unique course between rows ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 The ... recipients of the Bruce Simpson Winemaker Scholarship. The ... recipients will each receive $1,000 for the 2014/2015 ... Stemo, Alexis Bogdanova-Hanna and Ashley Nitz. , The ... careers as winemakers and vineyardists in northern Michigan. ...
(Date:8/26/2014)... Charles, LA (PRWEB) August 27, 2014 ... irreversible, it simply makes sense to use hearing ... risk losing hearing forever. There are many different ... and recreational use. Employers generally provide hearing protection ... law enforcement, and other noisy industries. The National ...
Breaking Medicine News(10 mins):Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 2Health News:Leelanau Peninsula’s Annual Harvest Stompede Offers One-of-a-Kind Walk or Run Through the Vineyards for Walkers, Runners and Wine Tasting Spectators Alike 3Health News:The Leelanau Peninsula Vintners Association (LPVA) Awards Its First-ever Bruce Simpson Winemakers Scholarships 2Health News:The Hearing Center of Lake Charles Adds a Complete Line of Occupational Hearing Protection Products and Services to Its Offerings 2Health News:The Hearing Center of Lake Charles Adds a Complete Line of Occupational Hearing Protection Products and Services to Its Offerings 3
... N.C. The addition of a chemotherapeutic drug for leukemia ... to enhance the response of certain ovarian cancers to treatment, ... Duke Comprehensive Cancer Center. , "We know that a ... types of cancers, including some ovarian cancers," said Deanna Teoh, ...
... 18 "Getting closer to controlling cancer" requires funding ... of the new federal stimulus, say former White House ... Washington University Medical Center breast cancer laboratory director, ... Denver Post. Weiner, Berg, and former government analyst Paulette ...
... Awareness Month , , SATURDAY, April 18 (HealthDay News) -- ... 200 sites across the United States in May, which ... and children with symptoms such as wheezing, coughing and ... the screenings that will be conducted by allergists. , ...
... (Nasdaq: ISTA ), today announced it will release first ... a conference call to discuss these results and provide a pipeline ... Date: Thursday, May 7, 2009, Time: 5:00 ... Internet: www.istavision.com, Domestic dial-in: 866-356-3377, ...
... PTU can cause liver disease, experts say , , FRIDAY, April ... of the antithyroid drug (PTU) in children has been endorsed ... editor in the April 9 New England Journal of ... liver disease in children and should no longer be used ...
... Perspective HARRISBURG, Pa., April 17 Agriculture ... the first meeting of the Governor,s Food Safety Council on ... The council will meet from 1 p.m. to 4 p.m. ... Harrisburg Area Community College . The council will hear a ...
Cached Medicine News:Health News:Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers 2Health News:Getting Closer to Controlling Cancer Requires Funding More Laboratories and Commitment Beyond Two Years of New Stimulus, Weiner and Berg Assert in Denver Post Oped 2Health News:Group Urges Public to Take Free Asthma Tests in May 2Health News:Drug May Be Dangerous for Kids With Graves' Disease 2Health News:Pennsylvania Governor's Food Safety Council to Hold First Meeting on April 22 2
(Date:8/26/2014)... DIEGO , Aug. 26, 2014 Profil ... research organization (CRO) focused on diabetes and obesity, announced ... completion of more than 200 phase I – IIa ... the treatment of type 1 and type 2 diabetes. ... of research is what it represents for the public ...
(Date:8/26/2014)... , Aug. 26, 2014  Ruthigen Inc. (NASDAQ: ... on improving patient outcomes and reducing healthcare costs ... drug candidate, RUT58-60, has received a recommendation from ... patients in the Company,s planned Phase 1/2 clinical ... as an adjunct therapy in combination with prophylactic ...
(Date:8/26/2014)...   Organovo Holdings, Inc. (NYSE MKT: ONVO) ... 3D bioprinting technology, announced today that it has been recognized ... World Economic Forum (WEF) .  Organovo is one ... creativity to design and create transformative solutions. ... Pioneer by the World Economic Forum for the innovation ...
Breaking Medicine Technology:Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 2Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes 3Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 2Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 3Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60 4Organovo Named 2015 Technology Pioneer by World Economic Forum 2Organovo Named 2015 Technology Pioneer by World Economic Forum 3
... Primary Endpoint, with Positive Effect Sustained Through ... Duration of 4-Week ... VNDA ) (Vanda) today announced positive top-line results from,a Phase III ... agonist, met the primary endpoint,of the trial and significantly improved sleep ...
... with initiatives aimed at knowledge transfer, including landmark ... Massachusetts and the Italian government in ... an innovator and,leader in global patient recruitment for clinical ... of initiatives to make its,quarter-century of expertise more accessible ...
Cached Medicine Technology:Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 2Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 3Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 4Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 5Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 6Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 7Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 8Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia 9BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 2BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 3BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment 4
... is lightweight enough to shuttle easily between ... Designed with a goldmann standard 30 cm ... with 79 locations (including 30-2, 24-2, and ... different suprathresholds out to 30. Easyfield ...
The Oculus easyfield is an exciting new compact perimeter to do automatic static perimetry up to 30 degrees eccentricity. It has been designed for the combined use as a visual field screener and peri...
... The Octopus 311 has additional hardware ... requirements of the most demanding clinics or ... of user defined test parameters for experimental ... LAN adapter (Option). Capacity for further tests ...
... Designed around the patented Interzeag ... 301 sets the trend in ... Ideal for routine screening and ... performance, accuracy and quality of ...
Medicine Products: